Y0000235
Almagate
European Pharmacopoeia (EP) Reference Standard
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
grade
pharmaceutical primary standard
API family
almagate
manufacturer/tradename
EDQM
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
2-8°C
InChI
1S/CH2O3.Al.3Mg.9H2O/c2-1(3)4;;;;;;;;;;;;;/h(H2,2,3,4);;;;;9*1H2/q;+3;3*+2;;;;;;;;;/p-9
InChI key
MTEOMEWVDVPTNN-UHFFFAOYSA-E
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
Application
Almagate EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
Packaging
The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
Other Notes
Sales restrictions may apply.
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Choose from one of the most recent versions:
Certificates of Analysis (COA)
Lot/Batch Number
Sorry, we don't have COAs for this product available online at this time.
If you need assistance, please contact Customer Support.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
E Rey et al.
Alimentary pharmacology & therapeutics, 20(6), 683-688 (2004-09-09)
To compare the effect of effervescent ranitidine, almagate (magnesium carbonate-aluminium hydroxide) and placebo on gastric pH, in fasting and postprandial conditions. Twelve healthy volunteers underwent a gastro-oesophageal pH monitoring on three different occasions after the administration of each of the
P Arizón Deza et al.
Atencion primaria, 15(2), 106-108 (1995-02-15)
To find the characteristics of our patients being treated with anti-ulcer medication and to evaluate whether the prescriptions were correct. A descriptive, crossover study. Perpetuo Socorro Health Centre in Huesca. 71 patients selected through their long-treatment booklets during october-november 1992.
E Nagy et al.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies, 32(3), 119-121 (1994-03-01)
The kinetics of aluminium absorption were determined in patients with duodenal ulcer and in 2 normal males after taking the antacid Tisacid (Biogal, Hungary). A peak serum aluminium of 54.5 micrograms/l was reached at 30 min, returning to the initial
The kinetics of initial gastrointestinal absorption of an aluminium-containing antacid (Tisacid) in patients with various stages of chronic renal insufficiency.
Z Sárszegi et al.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 12(2), 372-373 (1997-02-01)
V G Mysh et al.
Klinicheskaia meditsina, 67(10), 66-68 (1989-10-01)
Forty-three patients with duodenal ulcer were treated with almagel and gastrocepin, had four meals a day. Twenty-one patients received the drugs according to the standard schedule before meals. The test group of 22 patients took meals and drugs in turn
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service